Top Markets
Coin of the day
Jafron Biomedical Co.,Ltd. Jafron Biomedical Co.,Ltd.

Jafron Biomedical Co.,Ltd.

300529
Rang in aandelen #6731
Jafron Biomedical Co.,Ltd. engages in the research and development, production,... Jafron Biomedical Co.,Ltd. engages in the research and development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.
Aandeelprijs
$2.37
Laatst gesynchroniseerd: 2026-08-12
Marktkapitalisatie
$1.89B
Verandering (1 dag)
-0.24%
Verandering (1 jaar)
-28.81%
Land
CN
Handel Jafron Biomedical Co.,Ltd. (300529)

Categorie

Dividendrendementgeschiedenis voor Jafron Biomedical Co.,Ltd. (300529)
Het dividendrendement (TTM) van Jafron Biomedical Co.,Ltd. (aandelsymbool: 300529) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Jafron Biomedical Co.,Ltd. (300529) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten